EMCURE - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 4.0
| Stock Code | EMCURE | Market Cap | 31,853 Cr. | Current Price | 1,680 ₹ | High / Low | 1,770 ₹ |
| Stock P/E | 47.9 | Book Value | 170 ₹ | Dividend Yield | 0.18 % | ROCE | 13.5 % |
| ROE | 11.6 % | Face Value | 10.0 ₹ | DMA 50 | 1,564 ₹ | DMA 200 | 1,447 ₹ |
| Chg in FII Hold | -0.24 % | Chg in DII Hold | 0.00 % | PAT Qtr | 282 Cr. | PAT Prev Qtr | 118 Cr. |
| RSI | 59.2 | MACD | 34.7 | Volume | 2,91,097 | Avg Vol 1Wk | 5,65,206 |
| Low price | 950 ₹ | High price | 1,770 ₹ | PEG Ratio | -3.54 | Debt to equity | 0.50 |
| 52w Index | 89.0 % | Qtr Profit Var | 462 % | EPS | 33.7 ₹ | Industry PE | 30.1 |
📈 Chart Patterns: Price is trading well above both 50 DMA (1,564 ₹) and 200 DMA (1,447 ₹), confirming strong bullish momentum. Trendlines show higher highs with resistance near 1,700–1,720 ₹.
📊 Moving Averages: Current price (1,680 ₹) above both 50 DMA and 200 DMA, reinforcing bullish strength.
📉 RSI: At 59.2, RSI is moderately strong, suggesting momentum but not yet overbought.
📊 MACD: Strongly positive at 34.7, confirming bullish crossover and momentum continuation.
📉 Bollinger Bands: Price near upper band, indicating strong momentum but also risk of short-term pullback.
📊 Volume Trends: Current volume (2.91L) is below 1-week average (5.65L), showing reduced participation despite bullish price action.
🎯 Momentum Signals: Bullish. MACD and moving averages confirm strength, though volume weakness suggests caution.
💹 Entry Zone: 1,630–1,650 ₹ (support levels).
💹 Exit Zone: 1,700–1,720 ₹ (resistance levels).
📌 Trend Status: Trending upward with strong bullish bias.
Positive
- Strong quarterly PAT growth (282 Cr. vs 118 Cr.), showing robust earnings momentum.
- EPS of 33.7 ₹ supports valuation strength.
- Price trading above both 50 DMA and 200 DMA confirms bullish trend.
- ROCE (13.5%) and ROE (11.6%) provide moderate profitability.
Limitation
- High P/E (47.9) compared to industry average (30.1) reflects premium valuation.
- Negative PEG ratio (-3.54) indicates valuation concerns relative to growth.
- Debt-to-equity ratio at 0.50 is higher than peers, adding financial risk.
- Volume below average, limiting breakout confirmation.
Company Negative News
- FII holdings reduced (-0.24%).
- Premium valuation limits upside potential in near term.
Company Positive News
- Significant PAT surge highlights operational efficiency.
- DII holdings stable, showing domestic support.
- Strong 52-week performance (+89%).
Industry
- Pharma sector remains resilient with strong demand drivers.
- Industry PE at 30.1 is lower than EMCURE’s P/E, suggesting premium positioning.
Conclusion
⚖️ EMCURE is trending upward with strong earnings momentum and technical strength above key moving averages. Entry near 1,630–1,650 ₹ offers a favorable setup, with exits around 1,700–1,720 ₹. Long-term investors should be cautious due to premium valuation and higher debt, while short-term traders can capitalize on bullish momentum with disciplined risk management.